Rhumbline Advisers Heron Therapeutics, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 175,786 shares of HRTX stock, worth $311,141. This represents 0.0% of its overall portfolio holdings.

Number of Shares
175,786
Previous 184,472 4.71%
Holding current value
$311,141
Previous $645,000 45.89%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$1.73 - $3.67 $15,026 - $31,877
-8,686 Reduced 4.71%
175,786 $349,000
Q2 2024

Aug 01, 2024
BUY
$2.32 - $3.86 $102,613 - $170,727
44,230 Added 31.54%
184,472 $645,000
Q1 2024

May 09, 2024
BUY
$1.71 - $3.06 $7,600 - $13,601
4,445 Added 3.27%
140,242 $388,000
Q4 2023

Feb 08, 2024
BUY
$0.54 - $1.82 $321 - $1,082
595 Added 0.44%
135,797 $230,000
Q3 2023

Nov 09, 2023
SELL
$0.97 - $1.8 $2,149 - $3,988
-2,216 Reduced 1.61%
135,202 $139,000
Q2 2023

Aug 08, 2023
BUY
$1.11 - $2.88 $1,080 - $2,802
973 Added 0.71%
137,418 $159,000
Q1 2023

May 11, 2023
BUY
$1.51 - $3.25 $5,372 - $11,563
3,558 Added 2.68%
136,445 $206,000
Q4 2022

Feb 14, 2023
BUY
$2.25 - $4.67 $8,163 - $16,942
3,628 Added 2.81%
132,887 $332,000
Q3 2022

Nov 10, 2022
BUY
$2.66 - $5.37 $22,535 - $45,494
8,472 Added 7.01%
129,259 $545,000
Q2 2022

Aug 11, 2022
BUY
$2.3 - $6.29 $44,856 - $122,673
19,503 Added 19.26%
120,787 $337,000
Q1 2022

May 12, 2022
SELL
$4.63 - $9.94 $8,398 - $18,031
-1,814 Reduced 1.76%
101,284 $579,000
Q4 2021

Feb 10, 2022
SELL
$8.35 - $12.6 $16,207 - $24,456
-1,941 Reduced 1.85%
103,098 $941,000
Q3 2021

Nov 12, 2021
BUY
$10.13 - $15.0 $42,647 - $63,150
4,210 Added 4.18%
105,039 $1.12 Million
Q2 2021

Aug 05, 2021
SELL
$13.27 - $18.48 $53,703 - $74,788
-4,047 Reduced 3.86%
100,829 $1.57 Million
Q1 2021

May 06, 2021
SELL
$14.49 - $20.72 $147,247 - $210,556
-10,162 Reduced 8.83%
104,876 $1.7 Million
Q4 2020

Feb 10, 2021
BUY
$14.61 - $22.14 $2,571 - $3,896
176 Added 0.15%
115,038 $2.44 Million
Q3 2020

Nov 12, 2020
SELL
$13.67 - $17.77 $272,907 - $354,760
-19,964 Reduced 14.81%
114,862 $1.7 Million
Q2 2020

Aug 13, 2020
BUY
$10.89 - $21.47 $186,327 - $367,351
17,110 Added 14.53%
134,826 $1.98 Million
Q1 2020

May 06, 2020
BUY
$10.23 - $24.56 $45,922 - $110,249
4,489 Added 3.96%
117,716 $1.38 Million
Q4 2019

Feb 05, 2020
BUY
$17.42 - $26.61 $216,443 - $330,629
12,425 Added 12.33%
113,227 $2.66 Million
Q3 2019

Oct 23, 2019
BUY
$16.36 - $21.39 $18,388 - $24,042
1,124 Added 1.13%
100,802 $1.87 Million
Q2 2019

Aug 14, 2019
BUY
$16.93 - $26.22 $187,804 - $290,858
11,093 Added 12.52%
99,678 $1.85 Million
Q1 2019

May 01, 2019
SELL
$23.15 - $28.34 $22,131 - $27,093
-956 Reduced 1.07%
88,585 $2.17 Million
Q4 2018

Jan 31, 2019
BUY
$22.03 - $32.01 $676,585 - $983,091
30,712 Added 52.21%
89,541 $2.32 Million
Q3 2018

Nov 07, 2018
SELL
$30.0 - $40.85 $17,160 - $23,366
-572 Reduced 0.96%
58,829 $1.86 Million
Q2 2018

Aug 06, 2018
BUY
$26.4 - $42.0 $268,567 - $427,266
10,173 Added 20.67%
59,401 $2.31 Million
Q1 2018

May 02, 2018
BUY
$18.43 - $28.8 $116,514 - $182,073
6,322 Added 14.73%
49,228 $1.36 Million
Q4 2017

Feb 09, 2018
SELL
$14.8 - $18.85 $121,567 - $154,833
-8,214 Reduced 16.07%
42,906 $777,000
Q3 2017

Nov 06, 2017
BUY
$14.65 - $16.85 $748,908 - $861,372
51,120
51,120 $826,000

Others Institutions Holding HRTX

# of Institutions
176
Shares Held
121M
Call Options Held
80.4K
Put Options Held
94.9K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $210M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email